Bio Details

Anne M. McGeorge, our Board Chair, has over 40 years of experience providing strategic guidance and operational and financial oversight to health care organizations. Ms. McGeorge currently serves on the board of directors and as the chair of the Audit Committee of Dianthus Therapeutics (NASDAQ:DNTH), a clinical-stage biotechnology company, and is on the board and the Audit Committee chair of Nimbus Therapeutics and CitiusTech, both privately-held biotech and healthcare technology companies, respectively. She has also served on several other public and private company boards and is on the adjunct faculty at the Gillings School of Public Health at the University of North Carolina-Chapel Hill. Before her retirement in July 2017, Ms. McGeorge served as the Global Managing Partner of Grant Thornton LLP's Health Care Industry Practice. Ms. McGeorge was formerly a partner at Deloitte LLP and Arthur Andersen LLP.  Ms. McGeorge was selected to serve on the board of directors due to her significant leadership and governance experience, as well finance, accounting, and risk management experience.